0.9836
price up icon16.28%   0.1377
after-market 시간 외 거래: .93 -0.0536 -5.45%
loading
전일 마감가:
$0.8459
열려 있는:
$0.83
하루 거래량:
87,333
Relative Volume:
0.57
시가총액:
$40.52M
수익:
$2.72M
순이익/손실:
$-85.08M
주가수익비율:
-0.5096
EPS:
-1.93
순현금흐름:
$-70.93M
1주 성능:
-16.64%
1개월 성능:
-25.48%
6개월 성능:
-21.31%
1년 성능:
-88.71%
1일 변동 폭
Value
$0.83
$0.99
1주일 범위
Value
$0.83
$1.18
52주 변동 폭
Value
$0.83
$11.76

셰턱랩스 Stock (STTK) Company Profile

Name
명칭
Shattuck Labs Inc
Name
전화
512-900-4690
Name
주소
500 W. 5TH STREET, AUSTIN
Name
직원
75
Name
트위터
Name
다음 수익 날짜
2025-03-26
Name
최신 SEC 제출 서류
Name
STTK's Discussions on Twitter

STTK을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
STTK
Shattuck Labs Inc
0.9836 40.52M 2.72M -85.08M -70.93M -1.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

셰턱랩스 Stock (STTK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-17 개시 Leerink Partners Outperform
2024-10-02 다운그레이드 Citigroup Buy → Neutral
2024-10-02 다운그레이드 Needham Buy → Hold
2024-10-01 다운그레이드 H.C. Wainwright Buy → Neutral
2024-06-17 다운그레이드 BTIG Research Buy → Neutral
2022-08-31 개시 BTIG Research Buy
2022-06-01 개시 Citigroup Buy
2022-05-02 개시 H.C. Wainwright Buy
2021-04-14 개시 Berenberg Buy
2021-01-11 개시 Evercore ISI Outperform
2020-11-03 개시 Citigroup Buy
2020-11-03 개시 Cowen Outperform
2020-11-03 개시 Needham Buy
모두보기

셰턱랩스 주식(STTK)의 최신 뉴스

pulisher
05:00 AM

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference - TradingView

05:00 AM
pulisher
04:52 AM

24,446 Shares in Shattuck Labs, Inc. (NASDAQ:STTK) Acquired by Virtu Financial LLC - Defense World

04:52 AM
pulisher
Apr 01, 2025

STTK stock plunges to 52-week low, touches $0.93 - Investing.com

Apr 01, 2025
pulisher
Mar 31, 2025

Brokers Issue Forecasts for Shattuck Labs Q1 Earnings - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

515,619 Shares in Shattuck Labs, Inc. (NASDAQ:STTK) Acquired by Takeda Pharmaceutical Co. Ltd. - MarketBeat

Mar 30, 2025
pulisher
Mar 28, 2025

H.C. Wainwright holds Shattuck Labs stock at Neutral - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Shattuck Labs Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

Shattuck Labs (NASDAQ:STTK) Given Neutral Rating at HC Wainwright - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Shattuck Labs’ (STTK) “Hold” Rating Reaffirmed at Needham & Company LLC - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Shattuck Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

Shattuck Labs Inc (STTK) Q4 2024 Earnings: EPS of -$0.37 Misses Estimate, Revenue of $0.71M Below Expectations - GuruFocus

Mar 27, 2025
pulisher
Mar 27, 2025

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

Shattuck Labs, Inc Loss At -$18.68 Mln In Q4 - Nasdaq

Mar 27, 2025
pulisher
Mar 27, 2025

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business - Bluefield Daily Telegraph

Mar 27, 2025
pulisher
Mar 26, 2025

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of STTK, TLS and ASTR - ACCESS Newswire

Mar 26, 2025
pulisher
Mar 21, 2025

Leerink Partnrs Forecasts Shattuck Labs FY2024 Earnings - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Brokerages Set Shattuck Labs, Inc. (NASDAQ:STTK) Target Price at $7.50 - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

Shattuck Labs (NASDAQ:STTK) Upgraded at Leerink Partnrs - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Shattuck Labs (NASDAQ:STTK) Coverage Initiated by Analysts at Leerink Partners - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Leerink Partners Initiates Coverage of Shattuck Labs (STTK) with Outperform Recommendation - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Leerink initiates Shattuck Labs stock with Outperform, $4 target By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Leerink Partners Initiates Shattuck Labs at Outperform With $4 Price Target -March 17, 2025 at 07:39 am EDT - MarketScreener

Mar 17, 2025
pulisher
Mar 14, 2025

Stocks Recover Some of This Week’s Losses as US Shutdown Seems Averted - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

Stocks Rally as US Government Shutdown Risks Recede - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

Tariff Worries Pressure Stocks - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Tariff Worries Sink Stocks - TradingView

Mar 13, 2025
pulisher
Mar 02, 2025

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of STTK, RIVN and FB - ACCESS Newswire

Mar 02, 2025
pulisher
Feb 28, 2025

Shattuck Labs Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView

Feb 28, 2025
pulisher
Feb 27, 2025

Shattuck Labs (STTK) to Release Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 25, 2025

CLVT, SLI & STTK: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Upcoming Class Actions Deadlines and Encourages Shareholders to Contact the Firm - ACCESS Newswire

Feb 25, 2025
pulisher
Feb 22, 2025

Shattuck Labs (STTK) Projected to Post Earnings on Wednesday - MarketBeat

Feb 22, 2025
pulisher
Feb 20, 2025

Shattuck Labs reports positive preclinical SL-325 data By Investing.com - Investing.com Nigeria

Feb 20, 2025
pulisher
Feb 20, 2025

Shattuck Labs reports positive preclinical SL-325 data - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at ... - The Bakersfield Californian

Feb 20, 2025
pulisher
Feb 20, 2025

Breakthrough in IBD Treatment? Shattuck's Novel DR3 Blocker Achieves Perfect Safety Score - StockTitan

Feb 20, 2025
pulisher
Feb 19, 2025

Shattuck Labs (STTK) Expected to Announce Earnings on Wednesday - Defense World

Feb 19, 2025
pulisher
Feb 14, 2025

GoHealth to Announce Fourth Quarter 2024 Results on February 27, 2025 - The Manila Times

Feb 14, 2025
pulisher
Feb 13, 2025

Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - The Manila Times

Feb 13, 2025
pulisher
Feb 13, 2025

Revolutionary IBD Drug Development: Shattuck Labs Unveils Critical DR3 Antibody Results at ECCO 2025 - StockTitan

Feb 13, 2025
pulisher
Feb 12, 2025

Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights - br.ADVFN.com

Feb 12, 2025
pulisher
Feb 11, 2025

Anti-DR3 antibody demonstrates efficacy in the treatment of IBD - BioWorld Online

Feb 11, 2025
pulisher
Feb 04, 2025

Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn's and Colitis Congress - The Manila Times

Feb 04, 2025
pulisher
Feb 04, 2025

Skye Bioscience Announces Participation in February Conferences - The Manila Times

Feb 04, 2025
pulisher
Feb 04, 2025

Shattuck Labs, Inc. to Present Novel Research on SL-325 at 2025 Crohn’s and Colitis Congress - Nasdaq

Feb 04, 2025
pulisher
Feb 04, 2025

Pivotal IBD Drug Development: Shattuck Labs Reveals SL-325 Data at Major Crohn's Congress - StockTitan

Feb 04, 2025
pulisher
Feb 03, 2025

JPMorgan Chase & Co. Grows Position in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World

Feb 03, 2025
pulisher
Feb 03, 2025

Natera Announces National Commercial Coverage for its Fetal RhD NIPT - BioSpace

Feb 03, 2025
pulisher
Jan 30, 2025

Planet Image International Leads 3 US Penny Stocks To Consider - Simply Wall St

Jan 30, 2025
pulisher
Jan 29, 2025

Cresco Labs (OTCMKTS:CRLBF) Trading 2.1% Higher – What’s Next? - Defense World

Jan 29, 2025
pulisher
Jan 28, 2025

Vizient Forecasts a 3.84% Rise in Pharmacy Spending - BioSpace

Jan 28, 2025

셰턱랩스 (STTK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
자본화:     |  볼륨(24시간):